1049.2000 22.80 (2.22%)
NSE May 30, 2025 15:31 PM
Volume: 74,278
 

1049.20
2.22%
ICICI Securities Limited
Thyrocare Technologies(Thyrocare) Q2FY23 performance was below our estimates on all fronts. Non-covid pathology revenue grew by 4.6% QoQ, but volumes were flat sequentially.
Thyrocare Technologies Ltd. has gained 44.69% in the last 3 Months
More from Thyrocare Technologies Ltd.
Recommended